Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
The primary objective is to collaborate with or conduct research consistent with the division activities in measurement science, standards, technology, and data required to support the nation’s needs in determining the composition, structure, quantity, and function of biomolecules. In partnership with U.S. industry, government agencies, and scientific institutions, the division performs fundamental and applied research on the measurement of macromolecules such as proteins and nucleic acids, as well as peptides, glycans, metabolites, lipids, and natural products. Specific areas of interest include development of measurement methods, standards, reference data, and technologies for applications involving clinical diagnostics for. | Corrected - conforming to non-substantive changes in Federal Register version SECURITIES AND EXCHANGE COMMISSION 17 CFR PARTS 200 232 240 and 249 Release Nos. 33-9136 34-62764 IC-29384 File No. S7-10-09 RIN 3235-AK27 FACILITATING SHAREHOLDER DIRECTOR NOMINATIONS AGENCY Securities and Exchange Commission. ACTION Final rule. SUMMARY We are adopting changes to the federal proxy rules to facilitate the effective exercise of shareholders traditional state law rights to nominate and elect directors to company boards of directors. The new rules will require under certain circumstances a company s proxy materials to provide shareholders with information about and the ability to vote for a shareholder s or group of shareholders nominees for director. We believe that these rules will benefit shareholders by improving corporate suffrage the disclosure provided in connection with corporate proxy solicitations and communication between shareholders in the proxy process. The new rules apply only where among other things relevant state or foreign law does not prohibit shareholders from nominating directors. The new rules will require that specified disclosures be made concerning nominating shareholders or groups and their nominees. In addition the new rules provide that companies must include in their proxy materials under certain circumstances shareholder proposals that seek to establish a procedure in the company s governing documents for the inclusion of one or more shareholder director nominees in the company s proxy materials. We also are adopting related changes to certain of our other rules and regulations including the existing solicitation exemptions from our proxy rules and the beneficial ownership reporting requirements. DATES Effective Date November 15 2010 Compliance Dates November 15 2010 except that companies that qualify as smaller reporting companies as defined in 17 CFR 240.12b-2 as of the effective date of the rule amendments will not be subject to Rule 14a-11
